BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32551496)

  • 1. Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma.
    Reichel D; Sagong B; Teh J; Zhang Y; Wagner S; Wang H; Chung LWK; Butte P; Black KL; Yu JS; Perez JM
    ACS Nano; 2020 Jul; 14(7):8392-8408. PubMed ID: 32551496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative assessment and postsurgical treatment of prostate cancer tumors using tumor-targeted nanoprobes.
    Teh J; Tripathi M; Reichel D; Sagong B; Montoya R; Zhang Y; Wagner S; Saouaf R; Chung LWK; Perez JM
    Nanotheranostics; 2021; 5(1):57-72. PubMed ID: 33391975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo delineation of glioblastoma by targeting tumor-associated macrophages with near-infrared fluorescent silica coated iron oxide nanoparticles in orthotopic xenografts for surgical guidance.
    Lee C; Kim GR; Yoon J; Kim SE; Yoo JS; Piao Y
    Sci Rep; 2018 Jul; 8(1):11122. PubMed ID: 30042406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
    Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
    Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
    Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
    AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
    Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
    BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic targeting of paclitaxel-loaded poly(lactic-
    Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
    Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Advanced
    Chan MH; Chen W; Li CH; Fang CY; Chang YC; Wei DH; Liu RS; Hsiao M
    ACS Appl Mater Interfaces; 2021 Jun; 13(23):26759-26769. PubMed ID: 34076419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/NIR-II fluorescence imaging and image-guided surgery of glioblastoma using a folate receptor α-targeted dual-modal nanoprobe.
    Shi X; Xu P; Cao C; Cheng Z; Tian J; Hu Z
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4325-4337. PubMed ID: 35838757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
    Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
    Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
    Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
    Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
    Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models.
    Sandbhor P; Goda J; Mohanty B; Chaudhari P; Dutt S; Banerjee R
    Nanoscale; 2021 Dec; 14(1):108-126. PubMed ID: 34897360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Vascular Drug Delivery in Cerebral Cancer.
    Humle N; Johnsen KB; Arendt GA; Nielsen RP; Moos T; Thomsen LB
    Curr Pharm Des; 2016; 22(35):5487-5504. PubMed ID: 27464719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme.
    Kadiyala P; Li D; Nuñez FM; Altshuler D; Doherty R; Kuai R; Yu M; Kamran N; Edwards M; Moon JJ; Lowenstein PR; Castro MG; Schwendeman A
    ACS Nano; 2019 Feb; 13(2):1365-1384. PubMed ID: 30721028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.
    Sandbhor P; Goda J; Mohanty B; Gera P; Yadav S; Chekuri G; Chaudhari P; Dutt S; Banerjee R
    Drug Deliv Transl Res; 2023 Feb; 13(2):608-626. PubMed ID: 36245060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scaffolds biomimicking macrophages for a glioblastoma NIR-Ib imaging guided photothermal therapeutic strategy by crossing Blood-Brain Barrier.
    Lai J; Deng G; Sun Z; Peng X; Li J; Gong P; Zhang P; Cai L
    Biomaterials; 2019 Aug; 211():48-56. PubMed ID: 31085358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
    Kurbegovic S; Juhl K; Sørensen KK; Leth J; Willemoe GL; Christensen A; Adams Y; Jensen AR; von Buchwald C; Skjøth-Rasmussen J; Ploug M; Jensen KJ; Kjaer A
    Theranostics; 2021; 11(15):7159-7174. PubMed ID: 34158842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.